53
https://pubmed.ncbi.nlm.nih.gov/38095181
This review summarizes the latest findings on cancer stem cell (CSC) biomarkers, targeted agents, and related signalling pathways in various cancers, emphasizing their potential in improving prognostic outcomes for patients.